Myocardial Oxidative Stress in Anti-Cancer Therapies
This book summarizes the present knowledge of oxidative stress in anti-cancer drug-induced cardiotoxicity and covers cell molecular mechanisms, prevention and treatment strategies, drug research, and population experiments. Racial and gender disparities in anticancer therapy-related cardiotoxicity a...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Edition: | 1st ed. 2025. |
| Series: | Oxidative Stress in Applied Basic Research and Clinical Practice,
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-031-97517-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Part 1. Epidemiology & Cardiac Signaling
- 1. Risk Factors Associated with Anthracycline Induced Cardiac Dysfunction
- 2. Multilevel Drivers of Disparities in Cardio-oncology
- 3. Cardiotoxicity, Cancer Therapies, and Cardiac Cell Signaling
- 4. Phytochemicals in Cardiotoxicity and Cardioprotection
- Part II. Current Trends in Detection and Management
- 5. Detection, Prevention, & Management of Anthracycline-induced Cardiotoxicity
- 6. Pharmacotherapies in Prevention of Myocardial Oxidative Stress
- 7. Optimizing Cardiovascular Safety: Cardiotoxicity Prevention in Tyrosine Kinase Inhibitor, Monoclonal Antibody, Proteosome Inhibitor, and 5-Fluorouracil Anticancer Therapies
- 8. The Future of Cardio-oncology.